VALSARTAN/HYDROCHLOROTHIAZIDE VIATRIS 160 mg/12.5 mg, film-coated tablet 30 tablets
Active ingredients: HYDROCHLOROTHIAZIDE, Valsartan
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VALSARTAN/HYDROCHLOROTHIAZIDE VIATRIS 160 mg/12,5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) formée(s) à froid polyamide aluminium PVC-Aluminium de 30 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 7 Jul 2014
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69969418CIP72660410CIP133400926604103Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HYDROCHLOROTHIAZIDEcomprimé | 12,500 mg · un comprimé | SA |
| VALSARTANcomprimé | 160 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.